Zdrowie i gospodarka · 20/09/2018

FDA Releases Draft Guidance on Product Identifiers Under the Drug Supply Chain Security Act

The FDA is releasing a draft guidance to clarify product identifier requirements for certain drug products under the Drug Supply Chain Security Act, which mandates the use of product identifiers on packages and homogenous cases starting November 27, 2017, and November 28, 2018, respectively.